Matches in SemOpenAlex for { <https://semopenalex.org/work/W3158546989> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W3158546989 endingPage "A143" @default.
- W3158546989 startingPage "A143" @default.
- W3158546989 abstract "Abstract Introduction Daridorexant is a dual orexin receptor antagonist developed for the treatment of insomnia. The effect of the highest phase-3 dose of 50 mg daridorexant on nighttime respiratory function was evaluated in patients with mild/moderate obstructive sleep apnea (OSA). This study showed that repeated doses of daridorexant had no clinically meaningful effect on the apnea-hypopnea index (AHI) or on peripheral oxygen saturation. In the same study, the effect on objective sleep parameters was also explored by polysomnography (PSG). Methods In this randomized, double-blind, placebo-controlled, two-period, crossover study, daridorexant or placebo was administered in each period once daily for 5 consecutive nights to 28 patients. Treatment difference (daridorexant – placebo) for total sleep time (TST), latency to persistent sleep (LPS), and wake after sleep onset (WASO) was analyzed for Night 5 using linear mixed-effects modeling. In addition, sleep was further explored based on sleep duration during each hour of PSG recording, duration of the different sleep phases (rapid eye movement [REM], non-REM [including N1 to N3 sleep stages]), as well as number and mean/longest duration of awakenings. Results Of 28 patients enrolled, 25 completed the study and were included in the analysis (n=15/10 with mild/moderate OSA; mean [standard deviation] AHI: 16.3 [8.2] events/h). One patient had mild insomnia symptoms at baseline. Compared to placebo, daridorexant prolonged mean TST by 38.8 min (90% confidence interval: 19.7–57.9), shortened mean LPS by 17.2 min (-35.5–1.02), and reduced mean WASO by 31.0 min (-47.3 to 14.7). Sleep architecture was maintained as no treatment differences in the duration of the evaluated sleep stages were observed when normalized to TST. Sleep duration was prolonged in the second part of the night. mean and longest duration of awakenings were decreased by a mean (90% CI) of 2.0 min (-3.1 to 0.9) and 16.3 min (-24.1 to -8.6), respectively, without treatment difference for the total number of awakenings. Conclusion Daridorexant improved objective sleep parameters in patients with mild to moderate OSA without modifying sleep architecture. Support (if any) Funded by Idorsia Pharmaceuticals Ltd." @default.
- W3158546989 created "2021-05-10" @default.
- W3158546989 creator A5001224683 @default.
- W3158546989 creator A5013953658 @default.
- W3158546989 creator A5029825995 @default.
- W3158546989 creator A5046780212 @default.
- W3158546989 creator A5054290831 @default.
- W3158546989 creator A5058093690 @default.
- W3158546989 creator A5077060176 @default.
- W3158546989 date "2021-05-01" @default.
- W3158546989 modified "2023-10-06" @default.
- W3158546989 title "358 Daridorexant Improves Sleep in Patients with Mild/Moderate Obstructive Sleep Apnea" @default.
- W3158546989 doi "https://doi.org/10.1093/sleep/zsab072.357" @default.
- W3158546989 hasPublicationYear "2021" @default.
- W3158546989 type Work @default.
- W3158546989 sameAs 3158546989 @default.
- W3158546989 citedByCount "0" @default.
- W3158546989 crossrefType "journal-article" @default.
- W3158546989 hasAuthorship W3158546989A5001224683 @default.
- W3158546989 hasAuthorship W3158546989A5013953658 @default.
- W3158546989 hasAuthorship W3158546989A5029825995 @default.
- W3158546989 hasAuthorship W3158546989A5046780212 @default.
- W3158546989 hasAuthorship W3158546989A5054290831 @default.
- W3158546989 hasAuthorship W3158546989A5058093690 @default.
- W3158546989 hasAuthorship W3158546989A5077060176 @default.
- W3158546989 hasBestOaLocation W31585469891 @default.
- W3158546989 hasConcept C111919701 @default.
- W3158546989 hasConcept C118552586 @default.
- W3158546989 hasConcept C142724271 @default.
- W3158546989 hasConcept C204787440 @default.
- W3158546989 hasConcept C27081682 @default.
- W3158546989 hasConcept C2775841894 @default.
- W3158546989 hasConcept C2776006263 @default.
- W3158546989 hasConcept C2777935920 @default.
- W3158546989 hasConcept C2778205975 @default.
- W3158546989 hasConcept C2781210498 @default.
- W3158546989 hasConcept C2781326671 @default.
- W3158546989 hasConcept C2910364982 @default.
- W3158546989 hasConcept C41008148 @default.
- W3158546989 hasConcept C42219234 @default.
- W3158546989 hasConcept C63759246 @default.
- W3158546989 hasConcept C71924100 @default.
- W3158546989 hasConcept C87813604 @default.
- W3158546989 hasConceptScore W3158546989C111919701 @default.
- W3158546989 hasConceptScore W3158546989C118552586 @default.
- W3158546989 hasConceptScore W3158546989C142724271 @default.
- W3158546989 hasConceptScore W3158546989C204787440 @default.
- W3158546989 hasConceptScore W3158546989C27081682 @default.
- W3158546989 hasConceptScore W3158546989C2775841894 @default.
- W3158546989 hasConceptScore W3158546989C2776006263 @default.
- W3158546989 hasConceptScore W3158546989C2777935920 @default.
- W3158546989 hasConceptScore W3158546989C2778205975 @default.
- W3158546989 hasConceptScore W3158546989C2781210498 @default.
- W3158546989 hasConceptScore W3158546989C2781326671 @default.
- W3158546989 hasConceptScore W3158546989C2910364982 @default.
- W3158546989 hasConceptScore W3158546989C41008148 @default.
- W3158546989 hasConceptScore W3158546989C42219234 @default.
- W3158546989 hasConceptScore W3158546989C63759246 @default.
- W3158546989 hasConceptScore W3158546989C71924100 @default.
- W3158546989 hasConceptScore W3158546989C87813604 @default.
- W3158546989 hasIssue "Supplement_2" @default.
- W3158546989 hasLocation W31585469891 @default.
- W3158546989 hasOpenAccess W3158546989 @default.
- W3158546989 hasPrimaryLocation W31585469891 @default.
- W3158546989 hasRelatedWork W1963496047 @default.
- W3158546989 hasRelatedWork W2102426479 @default.
- W3158546989 hasRelatedWork W2319103027 @default.
- W3158546989 hasRelatedWork W2348551484 @default.
- W3158546989 hasRelatedWork W3030984161 @default.
- W3158546989 hasRelatedWork W3032263340 @default.
- W3158546989 hasRelatedWork W3098408806 @default.
- W3158546989 hasRelatedWork W3189765148 @default.
- W3158546989 hasRelatedWork W4308560183 @default.
- W3158546989 hasRelatedWork W93347451 @default.
- W3158546989 hasVolume "44" @default.
- W3158546989 isParatext "false" @default.
- W3158546989 isRetracted "false" @default.
- W3158546989 magId "3158546989" @default.
- W3158546989 workType "article" @default.